top of page

研究業績

2024

Matsumoto Y, Honda T, Yasui F, Endo A, Sanada T, Toyama S, Takagi A, Kono R, Yamaji K, Yamamoto N, Saeki Y, Kohara M.

Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation.

Frontiers in Immunology in press.

Honda T, Toyama S, Matsumoto Y, Sanada T, Yasui F, Koseki A, Kono R, Yamamoto N, Kamishita T, Kodake N, Miyazaki T, Kohara M.

Intranasally inoculated SARS-CoV-2 spike protein combined with mucoadhesive polymer induces broad and long-lasting immunity.

Vaccines 12(7), 794.

Ashida S, Kojima S, Okura T, Kato F, Furuyama W, Urata S, Matsumoto Y.

Phylogenetic analysis of the promoter element 2 of paramyxo- and filoviruses.

Microbiology Spectrum 12(5), e0041724.

2023

Kanno S, Matsumoto Y.

Analysis for the diagnostic accuracy of PCR detection of Macrorhabdus in companion birds.

Open Veterinary Journal 13, 1769-1775.

Toyama S, Honda T, Iwabuchi S, Hashimoto S, Yamaji K, Tokunaga Y, Matsumoto Y, Kawaji H, Miyazaki T, Kikkawa Y, Kohara M.

Application of spatial transcriptomics analysis using the Visium system for the mouse nasal cavity after intranasal vaccination.
Frontiers in Immunology 14, 1209945.

2022

Ishigaki H, Yasui F, Nakayama M, Endo A, Yamamoto N, Yamaji K, Nguyen CT, Kitagawa Y, Sanada T, Honda T, Munakata T, Higa M, Toyama S, Kono R, Takagi A, Matsumoto Y, Koseki A, Hayashi K, Shiohara M, Ishii K, Saeki Y, Itoh Y, Kohara M.

An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants.

Frontiers in Microbiology 13, 967019

 

Neriya Y, Kojima S, Sakiyama A, Kishimoto M, Iketani T, Watanabe T, Abe Y, Shimoda H, Nakagawa K, Koma T, Matsumoto Y.

A comprehensive list of the Bunyavirales replication promoters reveals a unique promoter structure in Nairoviridae differing from other virus families.

Scientific Reports 12, 13560

 

Yasui F, Matsumoto Y, Yamamoto N, Sanada T, Honda T, Munakata T, Itoh Y, Kohara M. Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.

Scientific reports 12, 4150

 

Saka N#, Matsumoto Y# (#Co-1st author), Ohta K, Kolakofsky D, Nishio M.

A point mutation in human parainfluenza virus type 2 nucleoprotein leads to two separate effects on virus replication.

Journal of Virology 96, e0206721

 

Sanada T, Honda T, Yasui F, Yamaji K, Munakata T, Yamamoto N, Kurano M, Matsumoto Y, Kohno R, Toyama S, Kishi Y, Horibe T, Kaneko Y, Kakegawa M, Fukui K, Kawamura T, Daming W, Qian C, Xia F, He F, Yamasaki S, Nishida A, Harada T, Higa M, Tokunaga Y, Takagi A, Itokawa M, Kodama T and Kohara M.

Serologic survey of IgG against SARS-CoV-2 among hospital visitors without a history of SARS-CoV-2 infection in Tokyo, 2020-2021.

Journal of Epidemiology 32, 105-111

 

2021

 

2020

Ohta K, Matsumoto Y, Nishio M.

Inhibition of Cavin3 degradation by the human parainfluenza virus type 2 V protein is important for efficient viral growth.

Frontiers in Microbiology 11, 803

 

Ohta K, Matsumoto Y, Nishio M.

Common and unique mechanisms of filamentous actin formation by viruses of the genus Orthorubulavirus.

Archives of Virology 165, 799-807

 

2019

Ohta K, Matsumoto Y, Nishio M.

Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.

Virology 533, 108-114

 

Matsumoto Y, Ohta K, Nishio M.

Importance of tyrosine in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein for polymerase activity.

Archives of Virology 164, 1851-1855

 

Matsumoto Y#, Nouchi T# (#Co-1st author), Ohta K, Nishio M.

Regulation of Hazara virus growth through apoptosis inhibition by viral nucleoprotein.

Archives of Virology 164, 1597-1607

 

Yumine N, Matsumoto Y, Ohta K, Fukasawa M, Nishio M.

Claudin-1 inhibits human parainfluenza virus type 2 dissemination.

Virology 531, 93-99

 

Matsumoto Y, Ohta K, Kolakofsky D, Nishio M.

A minigenome study of Hazara Nairovirus genomic promoters.

Journal of Virology 93, e02118-18

 

Ohtsuka J#, Matsumoto Y# (#Co-1st author), Ohta K, Fukumura M, Tsurudome M, Nosaka T, Nishio M.

Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.

Virology 528, 54-63

松本祐介

パラミクソウイルスの核酸蛋白によるウイルスゲノム複製制御メカニズム

和歌山医学 70, 146-149

 

2018

Ohta K, Matsumoto Y, Yumine N, Nishio M.

The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.

Virology 524, 90-96

 

Ohta K, Matsumoto Y, Nishio M.

Human parainfluenza virus type 2 V protein inhibits caspase-1.

Journal of General Virology 99, 501-511

 

Ohta K, Matsumoto Y, Nishio M.

Rab27a facilitates human parainfluenza virus type 2 growth by promoting cell surface transport of envelope proteins.

Medical Microbiology and Immunology 207, 141-150

 

Matsumoto Y, Ohta K, Kolakofsky D, Nishio M.

The control of paramyxovirus genome hexamer length and mRNA editing.

RNA 24, 461-467

 

Matsumoto Y, Ohta K, Nishio M.

Lethal infection of embryonated chicken eggs by Hazara virus; a model for Crimean-Congo hemorrhagic fever virus.

Archives of Virology 163, 219-222

 

2017

Matsumoto Y, Ohta K, Nishio M.

Human parainfluenza virus type 2 polymerase complex recognizes leader promoters of other species belonging to the genus Rubulavirus.

Medical Microbiology and Immunology 206, 441-446

 

Ohta K, Matsumoto Y, Ito M, Nishio M.

Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.

Medical Microbiology and Immunology 206, 319-326

 

Ohta K, Matsumoto Y, Yumine N, Nishio M.

Human parainfluenza virus type 2 V protein inhibits induction of tetherin.

Medical Microbiology and Immunology 206, 311-318

 

Matsumoto Y, Ohta K, Kolakofsky D, Nishio M.

A point mutation in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein elicits abnormally enhanced polymerase activity.

Journal of Virology 91, e02203-16

 

2016

Ohta K, Goto H, Matsumoto Y, Yumine N, Tsurudome M, Nishio M.

Graf1 Controls the Growth of Human Parainfluenza Virus Type 2 through Inactivation of RhoA Signaling.

Journal of Virology 90, 9394-9405

 

Goto H, Ohta K, Matsumoto Y, Yumine N, Nishio M.

Evidence that receptor destruction by the Sendai virus hemagglutinin-neuraminidase protein is responsible for homologous interference.

Journal of Virology 90, 7640-7646

 

Honda T, Yamamoto Y, Daito T, Matsumoto Y, Makino A, Tomonaga K.

Long-term expression of miRNA for RNA interference using a novel vector system based on a negative-strand RNA virus.

Scientific Reports 6, 26154

 

Matsumoto Y, Ohta K, Goto H, Nishio M.

Parainfluenza virus chimeric mini-replicons indicate a novel regulatory element in the leader promoter.

Journal of General Virology 97, 1520-1530

 

2015

Matsumoto Y, Ohta K, Yumine N, Goto H, Nishio M.

Identification of two essential aspartates for polymerase activity in parainfluenza virus L protein by a minireplicon system expressing secretory luciferase.

Microbiology and Immunology 59, 676-683

 

2014

Kojima S, Honda T, Matsumoto Y, Tomonaga K.

Heat stress is a potent stimulus for enhancing rescue efficiency of recombinant Borna disease virus.

Microbiology and Immunology 58, 636-642

 

2013

 

2012

Fujino K, Horie M, Honda T, Nakamura S, Matsumoto Y, Francischetti IM, Tomonaga K.

Evolutionarily conserved interaction between the phosphoproteins and X proteins of bornaviruses from different vertebrate species.

PLoS One 7, e51161

 

Nakamura S, Horie M, Fujino K, Matsumoto Y, Honda T, Tomonaga K.

Generation of human bronchial epithelial cell lines expressing inactive mutants of GALNT3.

The Journal of Veterinary Medical Science 74, 1493-1496

 

Matsumoto Y#, Hayashi Y# (#Co-1st author), Omori H, Honda T, Daito T, Horie M, Ikuta K, Fujino K, Nakamura S, Schneider U, Chase G, Yoshimori T, Schwemmle M, Tomonaga K.

Bornavirus closely associates and segregates with host chromosomes to ensure persistent intranuclear infection.

Cell Host & Microbe 11, 492-503

 

2011

Honda T, Fujino K, Okuzaki D, Ohtaki N, Matsumoto Y, Horie M, Daito T, Itoh M, Tomonaga K.

Upregulation of insulin-like growth factor binding protein 3 in astrocytes of transgenic mice that express Borna disease virus phosphoprotein.

Journal of Virology 85, 4567-4571

 

Daito T, Fujino K, Honda T, Matsumoto Y, Watanabe Y, Tomonaga K.

A novel Borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region.

Journal of Virology 85, 12170-12178

 

松本祐介, 藤野寛, 朝長啓造.

ボルナ病ウイルスの基本性状

臨床獣医 29, 12-16

2010

Matsumoto Y, Miura T, Akari H, Goto Y, Haga T.

Peripheral blood CD4 and CD8 double-positive T cells of rhesus macaques become vulnerable to simian immunodeficiency virus by in vitro stimulation due to the induction of CCR5.

The Journal of Veterinary Medical Science 72, 1057-1061

bottom of page